| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 03/21/2001 | EP1084133A1 Redox reversible bipyridyl osmium complex conjugates |
| 03/21/2001 | EP1084132A1 Redox reversible imidazole-osmium complex conjugates |
| 03/21/2001 | EP1083872A1 Pipecolic acid derivative hair growth compositions and uses |
| 03/21/2001 | CN1288467A Compounds with growth hormone releasing properties |
| 03/20/2001 | US6204406 Catalyst for asymmetric induction |
| 03/20/2001 | US6204393 In aqueous solution; controlling ph; neutralization |
| 03/20/2001 | US6204385 Reacting the corresponding nitrile with ammonia, amine or hydrazine in the presence of a mercaptocarboxylic acid |
| 03/20/2001 | US6204361 Method of peptide synthesis |
| 03/20/2001 | US6204279 Secondary amide containing benzoxazole derivatives |
| 03/20/2001 | US6204268 Cyclic diaza compounds |
| 03/20/2001 | US6204263 Thrombin inhibitors. |
| 03/20/2001 | US6204261 Inhibitors of interleukin-1β Converting enzyme inhibitors |
| 03/20/2001 | US6204035 Enzymatic protein associated with modulation of coagulation; for preparing tissues, and organs for grafting; anticoauglant; for diagnosis of defective coagulation in humans; for treating autoimmune and inflammatory diseases |
| 03/20/2001 | US6204008 Bioprocess for production of dipeptide based compounds |
| 03/20/2001 | CA2070169C Compounds with a sequence of three radicals, the central one being -aminoacidic and therapeutical applications thereof |
| 03/20/2001 | CA1341206C Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them |
| 03/15/2001 | WO2001018232A2 Drug target isogenes: polymorphisms in the uncoupling protein 3 (mitochondrial, proton carrier) gene |
| 03/15/2001 | WO2001018181A2 Enzyme inhibitors |
| 03/15/2001 | WO2001018034A1 Process for producing aspartame derivative, method of purifying the same, crystals thereof and use of the same |
| 03/15/2001 | WO2001018032A2 Dolastatin peptides |
| 03/15/2001 | WO2001017563A2 Integrin-mediated drug targeting |
| 03/15/2001 | WO2000061609A3 Prodrugs of thrombin inhibitors |
| 03/15/2001 | WO2000053583A8 Inhibitors of protein tyrosine phosphatase |
| 03/15/2001 | CA2383981A1 Integrin-mediated drug targeting |
| 03/15/2001 | CA2383137A1 Method for producing aspartame derivative, method for purifying the same, crystals thereof and uses of the same |
| 03/14/2001 | EP1082457A2 Nucleic acid encoding rate agouti related protein |
| 03/14/2001 | EP1082314A1 New dipeptidyl peptidase iv effectors |
| 03/14/2001 | EP1082126A1 Novel peptides |
| 03/14/2001 | EP0812205B1 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| 03/13/2001 | US6201103 Peptide nucleic acid incorporating a chiral backbone |
| 03/13/2001 | US6200969 Contacting cells with reagent which suppresses protease activity of interleukin-1.beta.-converting enzyme (ice)/ced-3 family, inhibiting apoptosis in cell population to expanding or increasing survival of cell population |
| 03/13/2001 | US6200967 Used as thrombin inhibitors, coagulation inhibitors and agents for the treatment of thromboembolic disorders |
| 03/13/2001 | CA2146238C Novel mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace |
| 03/08/2001 | WO2001016372A1 Methods of immobilizing ligands on solid supports and apparatus and methods of use therefor |
| 03/08/2001 | WO2001016300A2 Method of identifying inhibitors of cdc25 |
| 03/08/2001 | WO2001016211A1 Amphipathic compound having dendritic structure |
| 03/08/2001 | WO2001016161A1 SYNTHESIS OF TEMPLATE-FIXED β-HAIRPIN LOOP MIMETICS |
| 03/08/2001 | WO2001016135A2 Reverse-turn mimetics and methods relating thereto |
| 03/08/2001 | WO2001016117A1 Processes for the preparation of oxo-oxazoline or alloamino acid derivatives |
| 03/08/2001 | WO2000077184A9 Caspase-8 crystals, models and methods |
| 03/08/2001 | WO2000038786A3 Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 03/08/2001 | CA2384126A1 Reverse-turn mimetics and methods relating thereto |
| 03/08/2001 | CA2383603A1 Method of identifying inhibitors of cdc25 |
| 03/08/2001 | CA2382121A1 Methods of immobilizing ligands on solid supports and apparatus and methods of use therefor |
| 03/07/2001 | EP1081158A1 Process for the purification of aspartame derivative |
| 03/07/2001 | EP1080105A1 Phenylalanine derivatives having vla-4 antagonistic activity |
| 03/07/2001 | EP1080104A1 Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme |
| 03/07/2001 | EP1079859A1 Bifunctional molecules and therapies based thereon |
| 03/07/2001 | EP1079846A1 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 03/07/2001 | EP0641325B1 Retroviral protease inhibitors |
| 03/07/2001 | CN1286695A Process for preparation of N2-(1 (s)-carboxy-3-phenylpropyl)-L-lysyl-L-proline |
| 03/07/2001 | CN1286260A Crystal of methyl ester of alpha-L-asparaginyl-L-phenylalanine |
| 03/06/2001 | US6197998 Adding dropwise to aqueous suspension of tyrosine two equivalents or more of haloacetyl halide and aqueous solution of inorganic base simultaneously to form n-haloacetyltyrosine, reacting with ammonium ion to form n-glycyltyrosine |
| 03/06/2001 | US6197946 Nucleotide sequences coding hybrid albumin polypeptide; for production of heterologous polypeptide in hybrid animals |
| 03/06/2001 | US6197794 Antiinflamamtory agents; immunology diseases |
| 03/06/2001 | US6197750 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 03/06/2001 | US6197748 Ketoheterocyclic inhibitors of factor Xa |
| 03/06/2001 | CA1341196C Process for the preparation of substituted imino diacids |
| 03/01/2001 | WO2001014412A1 Compounds useful to mimic peptide beta-strands |
| 03/01/2001 | WO2001014395A2 Novel glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof |
| 03/01/2001 | WO2001014320A1 Compounds that inhibit tryptase activity |
| 03/01/2001 | WO2001014318A2 New effectors of dipeptidyl peptidase iv for topical use |
| 03/01/2001 | WO2000075365A3 COMPOUNDS AND METHODS TO ENHANCE rAAV TRANSDUCTION |
| 03/01/2001 | DE19941062A1 Pure methyl 2-acetamido-3-chloropropionate preparation for use as intermediate for hypotensive agent ramipril, from methyl serinate hydrochloride by chlorination, acetylation and purification |
| 03/01/2001 | DE19940130A1 Neue Effektoren der Dipeptidyl Peptidase IV zur topischen Anwendung New effectors of dipeptidyl peptidase IV for topical use |
| 03/01/2001 | DE19939910A1 Neue Verbindungen, die Tryptase-Aktivität hemmen Novel compounds that inhibit tryptase activity |
| 03/01/2001 | CA2381096A1 Compounds that inhibit tryptase activity |
| 03/01/2001 | CA2379875A1 New effectors of dipeptidyl peptidase iv for topical use |
| 03/01/2001 | CA2316767A1 Somatostatin antagonists and agonists that act at the sst subtype 2 receptor |
| 02/28/2001 | EP1077995A1 Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| 02/28/2001 | EP1077994A1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same |
| 02/28/2001 | EP1077949A2 Combinations of protein farnesyltransferase and hmg coa reductase inhibitors and their use to treat cancer |
| 02/28/2001 | CN1285356A Depeptide compound, its medical salt or ester, the medicinal composition using same as active component and the application for treating and preventing cell from dying |
| 02/28/2001 | CN1062600C Process for preparation selenic antibody enzyme |
| 02/27/2001 | US6194578 Growth hormone secretagogues; useful for prophylaxis and therapy of osteoporosis and/or frailty, insulin resistance in mammals, congestive heart failure, obesity, accelerating bone fracture repair reducing cachexia and protein loss |
| 02/27/2001 | US6194429 Purification with a hydrophobic resin |
| 02/27/2001 | US6194409 Heterocyclic derivatives and their use as antithrombotic agents |
| 02/27/2001 | US6194386 Labelled peptide compounds |
| 02/27/2001 | US6194380 Agents for promoting bone formation |
| 02/27/2001 | US6194195 Pure culture; for production of hypotensive agents and therapies for asthma, cerebral apoplexy, angina pectoris, acute renal failure, cardiac infarction, and cerebral vasospasm |
| 02/27/2001 | US6194143 Substrates for human cytomegalovirus protease |
| 02/27/2001 | US6193981 Methods and compositions for impairing multiplication of HIV-1 |
| 02/27/2001 | CA2189526C Perfluoroalkyl ketone inhibitors of elastase and processes for making the same |
| 02/22/2001 | WO2001013112A1 Melanocortin metallopeptide constructs, combinatorial libraries and applications |
| 02/22/2001 | WO2001012653A1 Stabilisation of freeze-dried cake |
| 02/22/2001 | WO2001012593A1 Arylsulfonanilide derivatives |
| 02/22/2001 | WO2001012186A1 Cell adhesion inhibitors |
| 02/22/2001 | WO2000071514A8 α-AMINO-β-SULFONYL HYDROXAMIC ACID COMPOUNDS |
| 02/22/2001 | CA2380817A1 Cell adhesion inhibitors |
| 02/22/2001 | CA2379647A1 Melanocortin metallopeptide constructs, combinatorial libraries and applications |
| 02/21/2001 | EP1077218A2 Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors |
| 02/21/2001 | EP1077217A2 Neuroactive peptides and their use |
| 02/21/2001 | EP1077216A1 Crystallization of alpha-L-aspartyl-L-phenylalanine methyl ester from supersaturated solution |
| 02/21/2001 | EP1076663A1 Functionalized alkyl and alkenyl side chain derivatives of glycinamides as farnesyl transferase inhibitors |
| 02/21/2001 | EP1076645A1 Process for the preparation of methyl(2s)-2-[(3r)-3-(n-[tert-butyloxycarbonyl]-amino) -2-oxopyrr olidin-1-yl]propionate |
| 02/21/2001 | EP1076563A1 Dipeptide caspase inhibitors and the use thereof |
| 02/21/2001 | EP0835238B1 New cationic and polycationic amphiphiles, reactives containing the same and their use |
| 02/21/2001 | CN1284964A Method for separating and purifying aspartame and aspartame derivative |
| 02/21/2001 | CN1284943A Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith |
| 02/20/2001 | US6191282 Derivatives of 5-membered nitrogen containing heterocyclic ring is used as anticarcinogenic agent and anticoagulant |